[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option Skystar Bio-Pharmaceutical Co., Ltd. Skystar granted the option in connection with its previously announced public offering of 1,400,000 shares of common stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closing conditions. Net proceeds from the offering are expected to]
[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option Skystar Bio-Pharmaceutical Co., Ltd. Skystar granted the option in connection with its previously announced public offering of 1,400,000 shares of common stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closing conditions. Net proceeds from the offering are expected to]
[PROSPECTUS SKYSTAR BIO-PHARMACEUTICAL COMPANY This is a firm commitment public offering of 1,400,000 shares of our common stock at a price of $12.98 per share. Our common stock is traded on the NASDAQ Capital Market under the symbol SKBI. On June 30, 2009, the last reported market price of our common stock was $17.94 per share. On May 12, 2009,]
[PROSPECTUS SKYSTAR BIO-PHARMACEUTICAL COMPANY This is a firm commitment public offering of 1,400,000 shares of our common stock at a price of $12.98 per share. Our common stock is traded on the NASDAQ Capital Market under the symbol SKBI. On June 30, 2009, the last reported market price of our common stock was $17.94 per share. On May 12, 2009,]
[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Optionystar Bio-Pharmaceuticalystar granted the option innnection with its previously announced public offering of 1,400,000 shares ofmmon stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closingnditions.Net proceeds from the offering are expected to be used for]
[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Optionystar Bio-Pharmaceuticalystar granted the option innnection with its previously announced public offering of 1,400,000 shares ofmmon stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closingnditions.Net proceeds from the offering are expected to be used for]
[PROSPECTUSYSTAR BIO-PHARMACEUTICALMPANY This is a firmmmitment public offering of 1,400,000 shares of ourmmon stock at a price of $12.98 per share. Ourmmon stock is traded on the NASDAQpital Market under the symbolBI. On June 30, 2009, the last reported market price of ourmmon stock was $17.94 per share. On May 12, 2009, we effected a]
[PROSPECTUSYSTAR BIO-PHARMACEUTICALMPANY This is a firmmmitment public offering of 1,400,000 shares of ourmmon stock at a price of $12.98 per share. Ourmmon stock is traded on the NASDAQpital Market under the symbolBI. On June 30, 2009, the last reported market price of ourmmon stock was $17.94 per share. On May 12, 2009, we effected a]
